SLCH Consortium Pediatric Hematology/Oncology

Topics

• Hemoglobinopathies and Related Disorders 504
• Neutrophil, Myeloperoxidase and Oxidative Mechanisms 117
• Childhood Cancer Survivors' Quality of Life 96
• Glioma Diagnosis and Treatment 93
• Hematopoietic Stem Cell Transplantation 84
• Platelet Disorders and Treatments 82
• Neurofibromatosis and Schwannoma Cases 49
• Acute Myeloid Leukemia Research 44
• Ubiquitin and proteasome pathways 40
• Hemophilia Treatment and Research 27
• Protease and Inhibitor Mechanisms 23
• Vascular Malformations and Hemangiomas 23

Most cited

1. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.

   Nature · 2023 · 458 citations · Shalini Shenoy

2. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

   Blood advances · 2021 · 446 citations · Jorge Di Paola

3. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma.

   Science (New York, N.Y.) · 2021 · 559 citations · Laura Schuettpelz

4. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

   Nature medicine · 2024 · 168 citations · Mohamed Abdelbaki

5. Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.

   The Lancet. Haematology · 2023 · 134 citations · Michael DeBaun, Allison King

6. Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders.

   Science (New York, N.Y.) · 2021 · 390 citations · Laura Schuettpelz